Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Metz

Showing results (101-110 of 135) with videos related to

Pageof 14
Sort By:
Annals of Surgical Oncology|November 9, 2019
Grade is a Dominant Risk Factor for Metastasis in Patients with Rectal Neuroendocrine TumorsIan W Folkert, Andrew J Sinnamon, Seth J Concors, et al.
Cardiovascular and Interventional Radiology|December 6, 2023
Integrated Capecitabine-Temozolomide with Radioembolization for Liver-Dominant G2 NETs: Long-Term Outcomes of a Single-Institution Retrospective StudyMichael C Soulen, Ursina R Teitelbaum, Rosemarie Mick, et al.
Gastrointestinal Endoscopy|January 30, 2014
Effect of propofol anesthesia on force application during colonoscopyLouis Y Korman, Nadim G Haddad, David C Metz, et al.
BMJ Open Gastroenterology|November 9, 2021
Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumoursKaren Rico, Suzann Duan, Ritu L Pandey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2019
NANETS/SNMMI Procedure Standard for Somatostatin Receptor-Based Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATEThomas A Hope, Amanda Abbott, Karen Colucci, et al.
Cancer Research|November 23, 2016
Menin and Daxx Interact to Suppress Neuroendocrine Tumors through Epigenetic Control of the Membrane Metallo-EndopeptidaseZijie Feng, Lei Wang, Yanmei Sun, et al.
Gastrointestinal Endoscopy|July 31, 2012
Segmental increases in force application during colonoscope insertion: quantitative analysis using force monitoring technologyLouis Y Korman, Lawrence J Brandt, David C Metz, et al.
JAMA Network Open|March 23, 2021
Laboratory, Clinical, and Survival Outcomes Associated With Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine TumorsSarit T Kipnis, Matthew Hung, Shria Kumar, et al.
Techniques and Innovations in Gastrointestinal Endoscopy|August 30, 2021
A Multimodal Interdisciplinary QI Intervention Is Associated with Reduction in After Hours Inpatient Endoscopy CasesSonali Palchaudhuri, Sara Attalla, Shivan J Mehta, et al.
The Oncologist|March 7, 2020
Abnormal Pretreatment Liver Function Tests Are Associated with Discontinuation of Peptide Receptor Radionuclide Therapy in a U.S.-Based Neuroendocrine Tumor CohortJason M Heckert, Sarit T Kipnis, Shria Kumar, et al.
Pageof 14

Showing results (101-110 of 135) with videos related to

Sort By:
Pageof 14
Annals of Surgical Oncology|November 9, 2019
Grade is a Dominant Risk Factor for Metastasis in Patients with Rectal Neuroendocrine TumorsIan W Folkert, Andrew J Sinnamon, Seth J Concors, et al.
Cardiovascular and Interventional Radiology|December 6, 2023
Integrated Capecitabine-Temozolomide with Radioembolization for Liver-Dominant G2 NETs: Long-Term Outcomes of a Single-Institution Retrospective StudyMichael C Soulen, Ursina R Teitelbaum, Rosemarie Mick, et al.
Gastrointestinal Endoscopy|January 30, 2014
Effect of propofol anesthesia on force application during colonoscopyLouis Y Korman, Nadim G Haddad, David C Metz, et al.
BMJ Open Gastroenterology|November 9, 2021
Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumoursKaren Rico, Suzann Duan, Ritu L Pandey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2019
NANETS/SNMMI Procedure Standard for Somatostatin Receptor-Based Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATEThomas A Hope, Amanda Abbott, Karen Colucci, et al.
Cancer Research|November 23, 2016
Menin and Daxx Interact to Suppress Neuroendocrine Tumors through Epigenetic Control of the Membrane Metallo-EndopeptidaseZijie Feng, Lei Wang, Yanmei Sun, et al.
Gastrointestinal Endoscopy|July 31, 2012
Segmental increases in force application during colonoscope insertion: quantitative analysis using force monitoring technologyLouis Y Korman, Lawrence J Brandt, David C Metz, et al.
JAMA Network Open|March 23, 2021
Laboratory, Clinical, and Survival Outcomes Associated With Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine TumorsSarit T Kipnis, Matthew Hung, Shria Kumar, et al.
Techniques and Innovations in Gastrointestinal Endoscopy|August 30, 2021
A Multimodal Interdisciplinary QI Intervention Is Associated with Reduction in After Hours Inpatient Endoscopy CasesSonali Palchaudhuri, Sara Attalla, Shivan J Mehta, et al.
The Oncologist|March 7, 2020
Abnormal Pretreatment Liver Function Tests Are Associated with Discontinuation of Peptide Receptor Radionuclide Therapy in a U.S.-Based Neuroendocrine Tumor CohortJason M Heckert, Sarit T Kipnis, Shria Kumar, et al.
Pageof 14